BRCA1 and myelodysplastic syndrome: Similar conditions of functional BRCA1 haploinsufficiency may occur in R-loops-driven MDS and may offer opportunities to therapeutic treatments, such as PARP inhibitors that sensitize BRCA1-deficient tumors [240].